Murussi M, Campagnolo N, Beck M O, Gross J L, Silveiro S P
Endocrine Division, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Diabet Med. 2007 Oct;24(10):1136-42. doi: 10.1111/j.1464-5491.2007.02209.x. Epub 2007 Jun 11.
To analyse the risk factors for the development of micro- and macroalbuminuria and mortality rates in a cohort of normoalbuminuric Type 2 diabetes mellitus (DM) patients.
In this prospective study, 193 Type 2 DM patients with urinary albumin excretion (UAE) < 20 microg/min, 96 men (50%), aged 56.5 +/- 9 years, were followed for a mean period of 8 +/- 3 years. UAE and estimated glomerular filtration rate (eGFR; Modification of Diet in Renal Disease) were measured. The outcomes were development of persistent micro- and macroalbuminuria and mortality.
Twenty patients were lost to follow-up. Of the 173 remaining patients, 33 (19%) died. The Cox analysis [hazard ratio (HR), 95% confidence interval] revealed that the baseline significant predictors of mortality were higher UAE [above median (5 microg/min); HR 2.7, 1.2-6.1; P = 0.02], male sex (HR 3.9, 1.7-9.2; P = 0.002), age (HR 1.6, 1.3-1.9; P = 0.0001), and fasting plasma glucose (HR 1.2, 1.1-1.3; P = 0.004). Smoking and eGFR were not significant in this model. Follow-up renal data were available for 158 patients: 34 (22%) progressed to microalbuminuria and seven (4%) to macroalbuminuria, and the baseline predictors were a higher UAE (> 5 microg/min, HR 2.5, 1.2-5.1; P = 0.02), presence of diabetic retinopathy (HR 2.5, 1.3-5.0; P = 0.009), fasting glucose (HR 1.1, 1.0-1.2; P = 0.015), and male sex (HR 2.2, 1.1-4.7; P = 0.04), independently of smoking and hypertension. Lower GFR (HR 0.98, 0.97-1.00; P = 0.07) was of borderline significance.
In normoalbuminuric Type 2 DM patients, the development of micro- or macroalbuminuria and mortality rates was independently and positively associated with higher levels of albuminuria, although still in the traditionally established normal range.
分析一组尿白蛋白正常的2型糖尿病(DM)患者发生微量和大量白蛋白尿的危险因素及死亡率。
在这项前瞻性研究中,对193例尿白蛋白排泄率(UAE)<20微克/分钟的2型糖尿病患者进行了随访,其中96例男性(50%),年龄56.5±9岁,平均随访时间为8±3年。测量了UAE和估计肾小球滤过率(eGFR;采用肾脏疾病饮食改良公式)。观察指标为持续性微量和大量白蛋白尿的发生情况及死亡率。
20例患者失访。在其余173例患者中,33例(19%)死亡。Cox分析[风险比(HR),95%置信区间]显示,死亡率的基线显著预测因素为较高的UAE[高于中位数(5微克/分钟);HR 2.7,1.2 - 6.1;P = 0.02]、男性(HR 3.9,1.7 - 9.2;P = 0.002)、年龄(HR 1.6,1.3 - 1.9;P = 0.0001)和空腹血糖(HR 1.2,1.1 - 1.3;P = 0.004)。吸烟和eGFR在该模型中无显著意义。158例患者有随访肾脏数据:34例(22%)进展为微量白蛋白尿,7例(4%)进展为大量白蛋白尿,基线预测因素为较高的UAE(>5微克/分钟,HR 2.5,1.2 - 5.1;P = 0.02)、糖尿病视网膜病变的存在(HR 2.5,1.3 - 5.0;P = 0.009)、空腹血糖(HR 1.1,1.0 - 1.2;P = 0.015)和男性(HR 2.2,1.1 - 4.7;P = 0.04),与吸烟和高血压无关。较低的GFR(HR 0.98,0.97 - 1.00;P = 0.07)具有临界显著性。
在尿白蛋白正常的2型糖尿病患者中,微量或大量白蛋白尿的发生及死亡率与较高水平的白蛋白尿独立且呈正相关,尽管仍在传统确定的正常范围内。